Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry

Abstract Background Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation (AF). This analysis describes the antithrombotic prescription patterns for Chinese patients enrolled post-d...

詳細記述

書誌詳細

主要な著者:	Xiaoxia Liu, Guoze Feng, Sabrina Vogel Marler, Menno V Huisman, Gregory Y. H. Lip, Changsheng Ma
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-08-01
シリーズ:	Thrombosis Journal
主題:	Atrial fibrillation Oral anticoagulation Stroke Prevention China
オンライン･アクセス:	https://doi.org/10.1186/s12959-023-00527-x
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!